Dementia, Mortality Risk Up for GBA Carriers With Parkinson's

This article originally appeared here.
Share this content:
Dementia, Mortality Risk Up for <i>GBA</i> Carriers With Parkinson's
Dementia, Mortality Risk Up for GBA Carriers With Parkinson's

THURSDAY, Sept. 22, 2016 (HealthDay News) -- Parkinson's disease (PD) patients with glucocerebrosidase gene (GBA) mutations have increased risk for dementia and death, according to a study published online Sept. 15 in the Annals of Neurology.

Roberto Cilia, M.D., from the Parkinson Institute in Milan, and colleagues examined survival, dementia, and genotype-phenotype correlations in 2,764 unrelated PD patients, including 123 GBA carriers and 2,641 non-carriers. They analyzed brain perfusion and dopamine transporter imaging, including dementia with Lewy bodies (DLB) as an additional control group.

The researchers found that GBA carriers were at greater risk for dementia and death (hazard ratios, 3.16 and 1.85, respectively) than non-carriers in multivariable analysis adjusted by gender, age at onset, and disease duration. The mortality risk remained greater in carriers when dementia was introduced as a time-dependent covariate in the model (hazard ratio, 1.65). GBA carriers had worse motor symptoms, especially non-dopaminergic features, at last examination. The risk for dementia was increased for carriers of severe versus mild mutations; mortality risk was similar. Compared with PD non-carriers, GBA carriers exhibited reduced posterior parietal and occipital cortical synaptic activity and nigrostriatal function. Mild mutation carriers had neuroimaging features that overlapped with PD non-carriers, while carriers of severe mutations were more similar to DLB.

"Survival is reduced in GBA carriers compared to non-carriers; this seems to be partially independent from the increased risk for early dementia," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »